16-22347654-C-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001802.2(CDR2):āc.676G>Cā(p.Val226Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000186 in 1,614,006 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001802.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDR2 | NM_001802.2 | c.676G>C | p.Val226Leu | missense_variant | 5/5 | ENST00000268383.7 | NP_001793.1 | |
CDR2 | XM_024450143.2 | c.451G>C | p.Val151Leu | missense_variant | 4/4 | XP_024305911.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CDR2 | ENST00000268383.7 | c.676G>C | p.Val226Leu | missense_variant | 5/5 | 1 | NM_001802.2 | ENSP00000268383.2 | ||
CDR2 | ENST00000564542.5 | c.523G>C | p.Val175Leu | missense_variant | 7/7 | 5 | ENSP00000457432.1 | |||
CDR2 | ENST00000561630.1 | n.*422G>C | non_coding_transcript_exon_variant | 4/4 | 5 | ENSP00000455915.1 | ||||
CDR2 | ENST00000561630.1 | n.*422G>C | 3_prime_UTR_variant | 4/4 | 5 | ENSP00000455915.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152120Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461886Hom.: 0 Cov.: 32 AF XY: 0.00000138 AC XY: 1AN XY: 727246
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152120Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74298
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 27, 2023 | The c.676G>C (p.V226L) alteration is located in exon 5 (coding exon 5) of the CDR2 gene. This alteration results from a G to C substitution at nucleotide position 676, causing the valine (V) at amino acid position 226 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at